At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Radiolabeled autologous seminal fluid +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Seminal Fluid on Distal Colon Mucosal Permeability and Susceptibility to HIV Infection
In Brief
A clinical study evaluating Radiolabeled autologous seminal fluid and Radiolabeled Normosol-R for Human Immunodeficiency Virus (HIV). Completed, enrolled 11 participants across 1 site.
Detailed Summary
This research is being done to learn how seminal fluid affects the lining of the colon, and whether this might make it easier for HIV to get into the body and cause infection.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHuman Immunodeficiency Virus (HIV)
CountriesUnited States
CollaboratorsamfAR, The Foundation for AIDS Research
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
Primary CompletionDec 2009
First PostedJan 2010
TodayJul 2026
First PostedJan 21, 2010
Enrollment StartMar 1, 2008
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.4 years ago
Interventions
Radiolabeled autologous seminal fluidbiological
Autologous lymphocytes labeled with 250 microcuries In-111 and 500 microcuries Tc-99m in seminal fluid vehicle.
Radiolabeled Normosol-Rbiological
Autologous lymphocytes labeled with 250 microcuries In-111 and 500 microcuries Tc-99m in Normosol-R fluid vehicle.